Back to browse

EXP002104

Paper

The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide for bone repair (2023)

Peptide

RALA

Sequence: WEARLARALARALARHLARALARALRACEA

RNA

miRNA (plasmid)

All experiment fields

Experiment Id EXP002104
Paper The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide f
Peptide RALA
Delivery Success Class no
In Vivo Flag no
Uptake Confirmed yes
Label Confidence high
In Vitro Functional Effect yes
Endosomal Escape Evidence
Peptide Concentration variable (N:P 1–15)
Rna Concentration 1 µg/well
Mixing Ratio N:P = 6
Formulation Format noncovalent peptide–DNA nanoparticle
Formulation Components RALA + pmiR-26a
Size Nm 74.00
Zeta Mv 21.00
Model Scope in_vitro
Model Type in vitro
Cell Lines Or Primary Cells hBMSCs
Animal Model
Administration Route
Output Type gene regulation / differentiation
Output Value Upregulation of RUNX2, COL1, OCN, VEGF; increased mineralisation
Output Units
Output Notes Robust osteogenic and angiogenic differentiation in vitro
Toxicity Notes No significant cytotoxicity
Curation Notes